-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Entering the end of November, the procurement of drugs with volume has entered a high-frequency project cycle
1.
1.
In terms of the scope of procurement, the omissions are different
However, from the perspective of the pace of publication, the relevant work opinions of the provinces are strictly implemented in the relevant spirit, and the first step must be taken from a policy perspective
2.
2.
Starting from the Hubei and Guangdong versions of the relevant rules for the procurement of Chinese patent medicines in quantities, the stability of such quantities in procurement has begun to spread.
Including the recently launched national special rules for purchasing insulin in quantities, the author understands that it is also a manifestation of a balanced market structure
3.
3.
Some provinces vowed to complete 500 recruitment during the 14th Five-Year Plan period, while some provinces directly set themselves a small target of 100 centralized procurement.
The same 500 catalog, in the eyes of different provinces, is completely different in thinking and way of thinking, and it also confirms that the form and content of procurement with volume in each province are changed and different
4.
4.
Taking the implementation plan of the 45 variety alliance in Guangdong as an example, the quotation ≤ 0.
5.
Integrity
Integrity
"Pharmaceutical Price and Recruitment Credit Evaluation Operation Regulations (2020 Edition)" can be called the escort ship on the journey of integrity, especially in the context of the overall drug reform led by the reduction of drug prices, which means that pharmaceutical companies are in sales and accurate into the process-strokes, the need to be more stringent review and regulate some of their own behavior, including around colluding, false quotes, stock, commercial bribery and other acts
.
One province is punished, and the whole country reports that the establishment of this kind of integrity mechanism will help the self-purification of the originally disorderly pharmaceutical market, and it will also play a key role in the benign change of the entire pharmaceutical ecology
.
